The Journal of Headache and Pain Study On Migraine
The Journal of Headache and Pain recently announced the results of a study, according to that migraine is the leading cause of days lost due…
Study
Lilly’s Bamlanivimab and Etesevimab
On March 10, Eli Lilly and Company announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab (LY-CoV555) 700 mg and…
Multi-Year Study to Enhance Food Safety
Recently the U.S. Food and Drug Administration (FDA) announced about a new multi-year study to enhance food safety.The launch of this study follows a series…
No Link Between Antihypertensive and Cancer Risk
According to the press release from ESC (European Society of Cardiology), there is no evidence that blood pressure lowering drugs (antihypertensive as an example) increase…
Dapagliflozin Reduces Risk of Kidney Failure
Recently was confirmed, that treatment with dapagliflozin (Farxiga; AstraZeneca) reduced the risk of kidney failure and cardiovascular (CV) or renal death in patients with chronic…
Metabolic Syndrome Linked to COVID-19 Mortality
According to the article that published in “Diabetes Care” journal patients with high blood pressure, obesity and diabetes have more risks get COVID-19 with end-stage…
The Chemotherapy Optimization: A Medication Trial
A medication trial for the therapy of chemotherapy-induced neutropenia (CIN) has confirmed specific issues.The PROTECTIVE (Study 106) advantage trial discovered that a marine-derived small-molecule (Plinabulin,…
The Blood Cancer: An Up-To-Date Research
Lymphoma is a variety of blood cancer related conditions, forming from lymphocytes (a type of white blood cell). It has multiple subtypes. A rare subtype,…
COVID Studies Concerns
Two of the world’s heading pharmaceutical journals on Tuesday showed concern about potential flaws in the data and covid studies provided by a little company…
COVID-19: Patients Improvements
Systemic anticoagulation may be correlated with enhanced outcomes among COVID-19 patients, according to an analysis letter published May 6 in the Journal of the American…